The transduction of signals generated by protein kinases and phosphatases are critical for the ability of integrin ␣ IIb  3 to support stable platelet adhesion and thrombus formation. Unlike kinases, it remains unclear how serine/threonine phosphatases engage the signaling networks that are initiated following integrin ligation. Because protein-protein interactions form the backbone of signal transduction, we searched for proteins that interact with the catalytic subunit of protein phosphatase 2A (PP2Ac). In a yeast two-hybrid study, we identified a novel interaction between PP2Ac and an adaptor protein CIN85 (Cbl-interacting protein of 85 kDa). Truncation and alanine mutagenesis studies revealed that PP2Ac binds to the P3 block ( 396 PAIPPKKPRP 405 ) of the proline-rich region in CIN85. The interaction of purified PP2Ac with CIN85 suppressed phosphatase activity. Human embryonal kidney 293 ␣ IIb  3 cells overexpressing a CIN85 P3 mutant, which cannot support PP2Ac binding, displayed decreased adhesion to immobilized fibrinogen. Platelets contain the ϳ85 kDa CIN85 protein along with the PP2Ac-CIN85 complex. A myristylated cell-permeable peptide derived from residues 395-407 of CIN85 protein (P3 peptide) disrupted the platelet PP2Ac-CIN85 complex and decreased ␣ IIb  3 signaling dependent functions such as platelet spreading on fibrinogen and thrombin-mediated fibrin clot retraction. In a phospho-profiling study P3 peptide treated platelets also displayed decreased phosphorylation of several signaling proteins including Src and GSK3. Taken together, these data support a role for the novel PP2Ac-CIN85 complex in supporting integrindependent platelet function by dampening the phosphatase activity.An ischemic vascular event ensues when a blood vessel is occluded by platelet-rich thrombi at the site of ruptured atherosclerotic plaque. Exposure of platelets to collagen and/or von Willebrand factor under high shear stress within the milieu of plaque initiates the inside-out signaling processes that activates integrin ␣ IIb  3 (1). The activated integrin can engage fibrinogen and generate outside-in signals that facilitate cytoskeletal reorganization and support a cascade of functional changes, including platelet spreading, stable adhesion, granule secretion, and clot retraction; all processes that augment the size of the platelet thrombi (2, 3).The coordinated signaling networks that are initiated by the engagement of agonists and integrin receptors on platelets are essential to the development of thrombi (4, 5). Spatial and temporal assembly of multiprotein signaling complexes by adaptor proteins relay signals following the engagement of integrin. The reversible phosphorylation of proteins on tyrosine, serine, and threonine residues, under the control of kinases and phosphatases, is an essential component of signaling. Because the outside-in signaling process greatly amplifies the size of platelet thrombi, there is a desire to selectively target this signaling process in a new class of antithrombotic agents (6). ...